David Amsellem
Stock Analyst at Piper Sandler
(4.86)
# 374
Out of 5,133 analysts
822
Total ratings
59.8%
Success rate
14.2%
Average return
Main Sectors:
Stocks Rated by David Amsellem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics | Reiterated: Buy | $48 → $21 | $7.44 | +182.26% | 5 | Nov 13, 2026 | |
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 14,154 → ILA 18,014 | ILA 14,030 | +28.39% | 3 | Nov 12, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 → $330 | $241.55 | +36.62% | 73 | Nov 12, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $75 | $32.08 | +133.79% | 8 | Nov 10, 2026 | |
| AMGN Amgen | Reiterated: Buy | $457 | $465.67 | -1.86% | 59 | Nov 9, 2026 | |
| BIIB Biogen | Reiterated: Buy | $245 → $305 | $253.40 | +20.36% | 36 | Nov 9, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Hold | $43 → $28 | $25.32 | +10.58% | 47 | Nov 6, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Hold | $8 → $12 | $16.66 | -27.97% | 16 | Nov 6, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $165 → $173 | $72.94 | +137.18% | 38 | Nov 4, 2026 | |
| SUPN Supernus | Initiated Coverage: Buy | $47 | $29.72 | +58.14% | 1 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 → $215 | $167.40 | +28.43% | 46 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $238 → $235 | $141.69 | +65.86% | 30 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $78 | $63.43 | +22.97% | 22 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $303 | $295.03 | +2.70% | 30 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $14 | $20.82 | -32.76% | 27 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $47.03 | +38.21% | 43 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $20 | $29.37 | -31.90% | 41 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $21.38 | -20.49% | 42 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.91 | +104.60% | 7 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.62 | +54.91% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5 → $14 | $13.90 | +0.72% | 18 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $111 | $71.44 | +55.38% | 4 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $33.76 | +36.26% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $9 | - | n/a | 19 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $36.46 | n/a | 39 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4.26 | $11.91 | n/a | 64 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $4.83 | n/a | 9 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $12 | $1.18 | n/a | 12 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $17 | $0.90 | n/a | 29 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.0062 | n/a | 7 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $3 | $18.03 | n/a | 5 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $175 | $0.000001 | n/a | 7 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $28.89 | n/a | 1 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $0.906 | n/a | 10 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0002 | n/a | 1 | Nov 11, 2013 |
Pelthos Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $48 → $21
Current: $7.44
Upside: +182.26%
Teva Pharmaceutical Industries Limited
Nov 12, 2026
Reiterated: Buy
Price Target: ILA 14,154 → ILA 18,014
Current: ILA 14,030
Upside: +28.39%
Jazz Pharmaceuticals
Nov 12, 2026
Reiterated: Buy
Price Target: $310 → $330
Current: $241.55
Upside: +36.62%
Definium Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $75
Current: $32.08
Upside: +133.79%
Amgen
Nov 9, 2026
Reiterated: Buy
Price Target: $457
Current: $465.67
Upside: -1.86%
Biogen
Nov 9, 2026
Reiterated: Buy
Price Target: $245 → $305
Current: $253.40
Upside: +20.36%
Collegium Pharmaceutical
Nov 6, 2026
Reiterated: Hold
Price Target: $43 → $28
Current: $25.32
Upside: +10.58%
Xeris Biopharma Holdings
Nov 6, 2026
Reiterated: Hold
Price Target: $8 → $12
Current: $16.66
Upside: -27.97%
Corcept Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $165 → $173
Current: $72.94
Upside: +137.18%
Supernus
Nov 4, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $29.72
Upside: +58.14%
Nov 3, 2026
Reiterated: Buy
Price Target: $210 → $215
Current: $167.40
Upside: +28.43%
Nov 2, 2026
Reiterated: Buy
Price Target: $238 → $235
Current: $141.69
Upside: +65.86%
Oct 27, 2026
Reiterated: Buy
Price Target: $82 → $78
Current: $63.43
Upside: +22.97%
Oct 26, 2026
Reiterated: Buy
Price Target: $303
Current: $295.03
Upside: +2.70%
Oct 26, 2026
Rated: Hold
Price Target: $13 → $14
Current: $20.82
Upside: -32.76%
Oct 19, 2026
Reiterated: Buy
Price Target: $65
Current: $47.03
Upside: +38.21%
Aug 7, 2026
Reiterated: Hold
Price Target: $21 → $20
Current: $29.37
Upside: -31.90%
Jul 20, 2026
Reiterated: Buy
Price Target: $17
Current: $21.38
Upside: -20.49%
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $3.91
Upside: +104.60%
May 15, 2026
Reiterated: Buy
Price Target: $18
Current: $11.62
Upside: +54.91%
Apr 28, 2026
Upgraded: Hold
Price Target: $5 → $14
Current: $13.90
Upside: +0.72%
Apr 23, 2026
Reiterated: Buy
Price Target: $94 → $111
Current: $71.44
Upside: +55.38%
Apr 22, 2026
Reiterated: Buy
Price Target: $48 → $46
Current: $33.76
Upside: +36.26%
Mar 21, 2025
Downgraded: Hold
Price Target: $15 → $9
Current: -
Upside: n/a
Nov 7, 2024
Reiterated: Hold
Price Target: $11 → $12
Current: $36.46
Upside: n/a
Oct 31, 2024
Reiterated: Sell
Price Target: $4.26
Current: $11.91
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $21 → $18
Current: $4.83
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $1 → $12
Current: $1.18
Upside: n/a
Aug 9, 2023
Downgraded: Sell
Price Target: $26 → $17
Current: $0.90
Upside: n/a
May 25, 2022
Reiterated: Buy
Price Target: $2
Current: $0.0062
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $20 → $3
Current: $18.03
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $6 → $175
Current: $0.000001
Upside: n/a
Jan 23, 2019
Upgraded: Hold
Price Target: n/a
Current: $28.89
Upside: n/a
Oct 12, 2017
Reiterated: Hold
Price Target: $3 → $2
Current: $0.906
Upside: n/a
Nov 11, 2013
Initiated Coverage: Buy
Price Target: $6
Current: $0.0002
Upside: n/a